Zhai Zhao, Zhu Zi-Yu, Cong Xi-Liang, Han Bang-Ling, Gao Jia-Liang, Yin Xin, Zhang Yu, Lou Sheng-Han, Fang Tian-Yi, Wang Yi-Min, Li Chun-Feng, Yu Xue-Feng, Ma Yan, Xue Ying-Wei
Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang Province, China.
World J Gastrointest Oncol. 2020 Oct 15;12(10):1119-1132. doi: 10.4251/wjgo.v12.i10.1119.
Through analyzing the data from a single institution in Northeast China, this study revealed the possible clinicopathologic characteristics that influence the prognosis of patients with gastric cancer (GC).
To evaluate the changing trends of clinicopathologic features and survival duration after surgery in patients with GC in Northeast China, which is a high-prevalence area of GC.
The study analyzed the difference in clinicopathologic features and survival duration after surgery of 5887 patients who were histologically diagnosed with GC at the Harbin Medical University Cancer Hospital. The study mainly analyzed the data in three periods, 2000 to 2004 (Phase 1), 2005 to 2009 (Phase 2), and 2010 to 2014 (Phase 3).
Over time, the postoperative survival rate significantly increased from 2000 to 2014. In the past 15 years, compared with Phases 1 and 2, the tumor size was smaller in Phase 3 ( < 0.001), but the proportion of high-medium differentiated tumors increased ( < 0.001). The proportion of early GC gradually increased from 3.9% to 14.4% ( < 0.001). A surprising improvement was observed in the mean number of retrieved lymph nodes, ranging from 11.4 to 27.5 ( < 0.001). The overall 5-year survival rate increased from 24% in Phase 1 to 43.8% in Phase 3. Through multivariate analysis, it was found that age, tumor size, histologic type, tumor-node-metastasis stage, depth of invasion, lymph node metastasis, surgical approach, local infiltration, radical extent, number of retrieved lymph nodes, and age group were independent risk factors that influenced the prognosis of patients with GC.
The clinical features of GC in Northeast China changed during the observation period. The increasing detection of early GC and more standardized surgical treatment effectively prolonged lifetimes.
通过分析中国东北地区一家机构的数据,本研究揭示了可能影响胃癌(GC)患者预后的临床病理特征。
评估中国东北地区胃癌高发区GC患者术后临床病理特征和生存时间的变化趋势。
本研究分析了哈尔滨医科大学附属肿瘤医院5887例经组织学诊断为GC患者的临床病理特征及术后生存时间的差异。研究主要分析了三个时期的数据,2000年至2004年(第1阶段)、2005年至2009年(第2阶段)和2010年至2014年(第3阶段)。
随着时间的推移,2000年至2014年术后生存率显著提高。在过去15年中,与第1阶段和第2阶段相比,第3阶段肿瘤体积较小(<0.001),但高中分化肿瘤比例增加(<0.001)。早期GC的比例从3.9%逐渐增加到14.4%(<0.001)。回收淋巴结的平均数量有惊人的改善,从11.4个增加到27.5个(<0.001)。总体5年生存率从第1阶段的24%提高到第3阶段的43.8%。通过多因素分析发现,年龄、肿瘤大小、组织学类型、肿瘤-淋巴结-转移分期、浸润深度、淋巴结转移、手术方式、局部浸润、根治范围、回收淋巴结数量和年龄组是影响GC患者预后的独立危险因素。
观察期内中国东北地区GC的临床特征发生了变化。早期GC检出率的增加和更规范的手术治疗有效地延长了生存期。